Health Care Equipment & Supplies · Nasdaq

GEHCGE HealthCare Technologies Inc.

Last close
$83.02 +1.4%
52-week range
$58.75 to $89.77
Market cap
$37.5B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$20.6B
+5% vs FY24
Net income
$2.08B
+5% vs FY24
Free cash flow
$1.50B
-3% vs FY24
Net cash
-$6.01B
Cash $4.49B, debt $10.5B

Stock price

+46% since Dec 2022

Valuation vs its own history since 2022

Below its median since 2022 on all 4 multiples

Where each multiple sits today inside its own range since 2022, measured at every quarter end. The thin tick is the median.

P/E, trailing
17.5x
13.8x26.6x
44th percentile, below its median of 18.0x
Price / sales
1.7x
1.4x2.2x
44th percentile, below its median of 1.8x
EV / EBITDA
14.0x
11.5x18.5x
25th percentile, below its median of 14.7x
Price / free cash flow
19.9x
14.5x26.9x
25th percentile, below its median of 21.6x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
17.5x
Earnings yield
5.7%
Price / sales
1.7x
Price / book
3.2x
Price / operating cash flow
15.5x
EV / EBITDA
14.0x
EV / sales
2.1x
Free cash flow yield
5.0%

Profitability

Gross margin
39.9%
Operating margin
13.3%
Net margin
10.0%
Return on equity
18.5%
Return on capital
10.7%

Growth per year

Revenue, 3 years
+4.0%
Revenue, 5 years
n/aLess than 5 years of history
EPS, 3 years
+2.5%

Balance sheet

Cash and investments
$2.83B
Total debt
$9.97B
Net cash
-$7.15B
Debt / equity
0.86x
Current ratio
1.30x

Shares and dividend

Shares outstanding
452M
Share count, 5 years
n/aLess than 5 years of history
Beta, 1 year
0.65
Dividend yield
0.2%
Dividend per share, TTM
$0.14
Payout ratio
3.0%

Every year we have of the business

Last 19 quarters, fiscal 2021 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $5.51B
RevenueNet income
Gross profitLatest quarter $2.22B
EBITDALatest quarter $886M
Margins40 / 15 / 11%
GrossOperatingNet
Earnings per shareLatest quarter $1.36
Cash flowLatest quarter $907M
OperatingCapexFree
Cash vs debtLatest quarter $2.83B
Cash and investmentsTotal debt
P/E historyNow 17.5x
P/E, median 18.0x dashed
P/S historyNow 1.7x
P/S, median 1.8x dashed

Where the revenue comes from

Services went from 34% to 34% of revenue in 3 years

Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.

ProductServices
FY22
66%34%
$18.3B
FY23
67%33%
$19.6B
FY24
66%34%
$19.7B
FY25
66%34%
$20.6B
Fiscal 2025 by product line
Product lineRevenueSharevs FY24
Product$13.7B66.2%+4%
Services$6.96B33.8%+6%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
GEHC GE HealthCare Technologies Inc. $37.5B +7% 13.3%17.5x1.7x 44th percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
Headquarters
Chicago, IL
Fiscal year ends
December

Around the numbers

What the rest of EdgeStacker knows about GEHC.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 927 active funds. Crowd level: quiet.

Open the Smart money tab